Related Experiment Videos
Ibuproxam and ibuprofen. A pharmacological comparison
Arzneimittel-Forschung
|January 1, 1977
Summary
Ibuproxam, a derivative of ibuprofen, shows comparable anti-inflammatory and pain-relieving effects but significantly improved gastrointestinal tolerability. This suggests ibuproxam may offer a safer alternative to ibuprofen for managing pain and inflammation.
Area of Science:
- Pharmacology
- Drug Development
- Gastroenterology
Background:
- Ibuprofen is a widely used non-steroidal anti-inflammatory drug (NSAID).
- NSAIDs can cause gastrointestinal side effects.
- Ibuproxam is a derivative of ibuprofen developed to potentially improve tolerability.
Purpose of the Study:
- To compare the anti-inflammatory, analgesic, antipyretic effects, and tolerability of ibuprofen and its derivative, ibuproxam.
- To investigate the pharmacokinetic basis for potential differences in gastrointestinal toxicity.
Main Methods:
- Comparative study of ibuprofen and ibuproxam in animal models.
- Assessment of anti-inflammatory, analgesic, and antipyretic activities.
- Evaluation of acute and repeated oral toxicity, focusing on gastrointestinal damage.
Main Results:
- Both ibuprofen and ibuproxam demonstrated similar anti-inflammatory, analgesic, and antipyretic efficacy.
- Ibuproxam exhibited significantly reduced gastrointestinal damage compared to ibuprofen during oral administration.
- Acute toxicity was comparable between the two drugs upon parenteral administration.
Conclusions:
- Ibuproxam offers comparable therapeutic benefits to ibuprofen with enhanced gastrointestinal safety.
- The improved tolerability of ibuproxam is hypothesized to be due to its pharmacokinetic profile, releasing ibuprofen gradually and maintaining lower systemic concentrations.
- Ibuproxam represents a promising alternative NSAID with a potentially better safety profile for oral use.